RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Inhibikase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-17 5:52 pm Purchase | 2026-07-10 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | RA CAPITAL MANAGEMENT L.P. | 25,000,000 15.900% | 25,000,000 (New Position) | Filing |